
UNITY Biotechnology Inc
NASDAQ:UBX

Fundamental Analysis


Revenue & Expenses Breakdown
UNITY Biotechnology Inc
Balance Sheet Decomposition
UNITY Biotechnology Inc
Current Assets | 24.3m |
Cash & Short-Term Investments | 23.2m |
Other Current Assets | 1m |
Non-Current Assets | 13.4m |
PP&E | 12.4m |
Other Non-Current Assets | 1m |
Free Cash Flow Analysis
UNITY Biotechnology Inc
USD | |
Free Cash Flow | USD |
Earnings Waterfall
UNITY Biotechnology Inc
Revenue
|
0
USD
|
Operating Expenses
|
-28.5m
USD
|
Operating Income
|
-28.5m
USD
|
Other Expenses
|
2.5m
USD
|
Net Income
|
-26m
USD
|
UBX Profitability Score
Profitability Due Diligence
UNITY Biotechnology Inc's profitability score is 17/100. The higher the profitability score, the more profitable the company is.

Score
UNITY Biotechnology Inc's profitability score is 17/100. The higher the profitability score, the more profitable the company is.
UBX Solvency Score
Solvency Due Diligence
UNITY Biotechnology Inc's solvency score is 51/100. The higher the solvency score, the more solvent the company is.

Score
UNITY Biotechnology Inc's solvency score is 51/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
UBX Price Targets Summary
UNITY Biotechnology Inc
According to Wall Street analysts, the average 1-year price target for
UBX
is 5.1 USD
with a low forecast of 4.04 USD and a high forecast of 6.3 USD.
Dividends
Current shareholder yield for UBX is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?